Skip to contentSkip to Braille Studio

Library / Laws / 115th Congress / Senate Bills / S. 1049

S. 1049

To allow the Secretary of Health and Human Services to require that risk evaluation and mitigation strategies for certain drugs include communication plans that provide information about drug formulations or properties described in the drug labeling.

Print stageDateSize⠃
Introduced in Senate2017-05-041.3K⠃⠗⠋